Progenity Turns Around
BIOTECH: $100M IPO Gives Co. Boost
By FRED GRIER
FRONT PAGE
San Diego-based Progenity, a biotech company focused on precision medicine, anticipates better years ahead after overcoming hurdles of the past and becoming a newly publicly held company.
The women's health diagnostic firm became one of six publicly...
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.